1038 / 1851
3-ys OS years after SABR: 60%
3-ys OS after PME: 62%
110 Consecutive patients
2007 and 2010
PME: first choice (68 pts)
SABR: second best alternative (42 pts)
SBRT vs Surgery: both equally (highly) effective
in Oligometastatic disease
Widder et al. Radiot Oncol 2013